UCM-1306
UCM-1306 is a potent and orally active human dopamine D1 receptor allosteric modulator (PAM) . UCM-1306 increases the endogenous dopamine (DA) maximal effect both in human and mouse D1 receptors. UCM-1306 is not only for improving motor symptoms but also for addressing the key comorbid cognitive impairment associated with long-term Parkinson’s disease (PD) [1].
Product Specifications
CAS Number
2258608-78-3
UNSPSC
12352005
Target
Dopamine Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/ucm-1306.html
Purity
99.61
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=S(C1=CC=C(C2=C(OCF)C=CC=C2)C=C1)(C)=N
Molecular Formula
C14H14FNO2S
Molecular Weight
279.33
References & Citations
[1]García-Cárceles J, et, al. 2- (Fluoromethoxy) -4'- (S-methanesulfonimidoyl) -1,1'-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D1 Receptor for Parkinson's Disease. J Med Chem. 2022 Sep 22;65 (18) :12256-12272.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RU55400 50 Preparations
Saliva DNA Isolation Kit (Magnetic Bead System)
Sign In for Pricing
View Details 
BNCB1628-500 1x 500 µL
CD8A (Cytotoxic- & Suppressor T-Cell Marker) (UCHT4), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401739-100 1x 100 µL
P53 Tumor Suppressor Protein (TP53/1739), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
